As of January 22, 2025, Eledon Pharmaceuticals (ELDN) has a market cap of $0.25 billion USD. According to our data, Eledon Pharmaceuticals is ranked No.6876 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.25 B |
2.18%
|
Dec 31, 2024 | $0.25 B |
128.89%
|
Dec 29, 2023 | $0.11 B |
-21.05%
|
Dec 30, 2022 | $0.14 B |
-48.30%
|
Dec 31, 2021 | $0.26 B |
-71.36%
|
Dec 31, 2020 | $0.92 B |
47.51%
|
Dec 31, 2019 | $0.62 B |
-63.75%
|
Dec 31, 2018 | $1.72 B |
-60.59%
|
Dec 29, 2017 | $4.37 B |
-53.87%
|
Dec 30, 2016 | $9.46 B |
-88.78%
|
Dec 31, 2015 | $84.39 B |
-40.84%
|
Dec 31, 2014 | $142.65 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
First Majestic Silver
AG
|
$2.70 B |
10.900 M
|
Canada
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
Market Cap | = | ELDN Stock Price | * | ELDN Shares Outstanding |
= | $4.21 | * | 59.74 M | |
= | $0.25 B |